Medical Group Basics
Compliance
340B
Rev Cycle/Reimbursement
Specialty Strategy
100

Name 3 wholesalers that dominate Nuvance Health/Northwell's medical practice landscape 

Henry Schein, McKesson Med Surge, Besse

100

This occurs when drugs purchased under one class of trade are used in another setting.

What is diversion?

100

This factor determines whether a medical group may access 340B pricing.

What is ownership & MCR presence 

100

This billing model is most commonly used for infused or injected drugs in medical practices.

What is buy-and-bill?

100

This inventory model reduces upfront cost but increases governance complexity in medical groups.

hat is consignment?

200

This key difference separates medical groups from HOPDs in the eyes of manufacturers and payers.

What is site of care (class of trade) designation?

200

This absence often leads to inconsistent medical group decision-making.

What is lack of centralized governance?

200

This compliance risk occurs when 340B drugs are administered outside eligible locations or patients.

Diversion

200

This billing failure can result in lost revenue for medical practices.

 What is incomplete J-code or NDC capture?

200

This storage requirement is often underestimated and inappropriately managed in distributed medical practices.

What is cold-chain management?

300

This is the number of medical practices in the Nuvance Health system? (Bonus how many are in Northwell Health's ecosystem)

150 (1100)

300

This action performed by manufacturers can result from non-compliant medical group purchasing.

What is contract termination, chargebacks, or repayment demand?

300

This relationship is often scrutinized when medical practices dispense or administer 340B drugs.

What is a contract pharmacy arrangement?

300

What is the major billing differences between Medical Practices and the Hospital system?

DRG versus separatable reimbursable action 

300

This specialty drug challenge arises when manufacturers restrict distribution channels.

What are limited distribution drugs (LDDs)?

400

This drug manufactured by Novartis was Nuvance Health's largest spend in 2025 in our medical practices? (Hint it is used to lower LDL)  

Leqvio

400

This operational weakness commonly increases compliance risk across multiple medical practices vs retail pharmacies 

What is lack of inventory segregation or tracking?

400

This missing control commonly leads to adverse audit findings in medical groups.

What is insufficient auditable records tying drug to eligible patient and location?

400

This reimbursement model pays practices for each individual service provided.

What is fee-for-service?

400

This decision balances access, compliance, and financial control for high-cost therapies.

When should drugs flow through health-system specialty pharmacy versus direct-to-practice?

500

This reason explains why manufacturers treat medical groups differently in purchasing 

What is differences in purchasing intent, utilization patterns, and site-of-care economics?

500

This documentation is critical during an audit to prove compliant medical group purchasing.

What is drug purchase history, administration records, and site-of-care validation data?

500

What strategy is leveraged for a medical practice to receive 340B pricing even though they are not a registered 340B site? 

Clear bagging 

500

This portion of the claim determines how a physician service is reimbursed based on complexity and time.

What is an Evaluation & Management (E/M) code?

500

What is the highest cost specialty indication (disease state) that is witnessed in the medical practices today? What is second?

1st: Oncology 

2nd: Inflammatory

M
e
n
u